Clinical Trials Browser

Interventional × Pemetrexed × Endocrine × Clear all

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT00786552 2011-01-20

Panthera

Phase 2 Unknown

EndocrineHead & Neck

Recurrence, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT00424723 2010-08-12

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

Phase 2 Completed

Neuroendocrine Tumors